DE3684186D1 - Verwendung von pharmaceutischen zusammensetzungen fuer die herstellung von arzneimitteln fuer die behandlung psychiatrischer stoerungen. - Google Patents

Verwendung von pharmaceutischen zusammensetzungen fuer die herstellung von arzneimitteln fuer die behandlung psychiatrischer stoerungen.

Info

Publication number
DE3684186D1
DE3684186D1 DE8686304765T DE3684186T DE3684186D1 DE 3684186 D1 DE3684186 D1 DE 3684186D1 DE 8686304765 T DE8686304765 T DE 8686304765T DE 3684186 T DE3684186 T DE 3684186T DE 3684186 D1 DE3684186 D1 DE 3684186D1
Authority
DE
Germany
Prior art keywords
pharmaceutical compositions
treatment
production
compositions
psychiatric disorders
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE8686304765T
Other languages
English (en)
Inventor
Gabor Megyeri
Tibor Keve
Bela Stefko
Erik Bogsch
Janos Galambos
Anna Kassai
Ferenc Trischler
Eva Palosi
Dora Groo
Egon Karpati
Zsolt Szombathelyi
Laszlo Szporny
Bela Kiss
Istvan Laszlovszky
Erzsebet Lapis
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Richter Gedeon Vegyeszeti Gyar Nyrt
Original Assignee
Richter Gedeon Vegyeszeti Gyar RT
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Richter Gedeon Vegyeszeti Gyar RT filed Critical Richter Gedeon Vegyeszeti Gyar RT
Application granted granted Critical
Publication of DE3684186D1 publication Critical patent/DE3684186D1/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/48—Ergoline derivatives, e.g. lysergic acid, ergotamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D457/00—Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid
    • C07D457/02—Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid with hydrocarbon or substituted hydrocarbon radicals, attached in position 8

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Epidemiology (AREA)
  • Psychiatry (AREA)
  • Anesthesiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Hydrogenated Pyridines (AREA)
  • Medicinal Preparation (AREA)
DE8686304765T 1985-06-21 1986-06-20 Verwendung von pharmaceutischen zusammensetzungen fuer die herstellung von arzneimitteln fuer die behandlung psychiatrischer stoerungen. Expired - Fee Related DE3684186D1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HU852445A HU193780B (en) 1985-06-21 1985-06-21 Process for producing 2-halogeno-6-methyl-ergol-9-ene derivatives and acid additional salts thereof

Publications (1)

Publication Number Publication Date
DE3684186D1 true DE3684186D1 (de) 1992-04-16

Family

ID=10959389

Family Applications (1)

Application Number Title Priority Date Filing Date
DE8686304765T Expired - Fee Related DE3684186D1 (de) 1985-06-21 1986-06-20 Verwendung von pharmaceutischen zusammensetzungen fuer die herstellung von arzneimitteln fuer die behandlung psychiatrischer stoerungen.

Country Status (8)

Country Link
US (1) US4681887A (de)
EP (1) EP0208447B1 (de)
JP (1) JPS62425A (de)
AT (1) ATE73330T1 (de)
DE (1) DE3684186D1 (de)
DK (1) DK291786A (de)
FI (1) FI862636A (de)
HU (1) HU193780B (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU196394B (en) * 1986-06-27 1988-11-28 Richter Gedeon Vegyeszet Process for preparing 2-halogenated ergoline derivatives
GB9707934D0 (en) * 1997-04-18 1997-06-04 Danbiosyst Uk Improved delivery of drugs to mucosal surfaces
US7666876B2 (en) * 2002-03-19 2010-02-23 Vernalis (R&D) Limited Buprenorphine formulations for intranasal delivery
GB0300531D0 (en) 2003-01-10 2003-02-12 West Pharm Serv Drug Res Ltd Pharmaceutical compositions
CN103467296B (zh) * 2012-06-08 2016-03-09 上海医药工业研究院 一种3-溴-4-羟基苯甲酸甲酯的制备方法

Also Published As

Publication number Publication date
FI862636A (fi) 1986-12-22
JPH0368008B2 (de) 1991-10-25
EP0208447A1 (de) 1987-01-14
JPS62425A (ja) 1987-01-06
DK291786A (da) 1986-12-22
HU193780B (en) 1987-11-30
DK291786D0 (da) 1986-06-20
US4681887A (en) 1987-07-21
EP0208447B1 (de) 1992-03-11
FI862636A0 (fi) 1986-06-19
HUT41022A (en) 1987-03-30
ATE73330T1 (de) 1992-03-15

Similar Documents

Publication Publication Date Title
ES2102132T3 (es) Amidas de acidos carboxilicos heterociclicos sustituidos, su preparacion y su utilizacion como medicamentos.
NO170280C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive sulfamatderivater
HUT43843A (en) Process for production of derivatives of benzimidasole and medical compounds containing thereof
BG60431B1 (bg) Производни на бензоксазол- и бензотиазоламини
ES8801235A1 (es) Un procedimiento para la preparacion de acidos 3-hidroxifenoxialquilenheterociclilcarboxilicos.
DE3873578T2 (de) Verwendung von tetrahydrobenz(c,d)indol-6-carboxamiden zur herstellung von arzneimitteln zur behandlung von angstzustaenden.
DE2967356D1 (en) Cephalosporin derivatives, process for their preparation and pharmaceutical compositions containing them
FR2393577A1 (fr) Medicament a base d'acide b-(p-halogenophenyl)-g-aminobutyrique destine au traitement de la nevrose d'angoisse
DE3586649D1 (de) Verwendung von spergualinderivaten zur herstellung von arzneimitteln mit immunodepressiver wirkung.
DE3684186D1 (de) Verwendung von pharmaceutischen zusammensetzungen fuer die herstellung von arzneimitteln fuer die behandlung psychiatrischer stoerungen.
FR2432520A1 (fr) Nouvelles imidazoquinoxalines et leurs sels, leur procede de preparation, leur application a titre de medicaments et les compositions pharmaceutiques les renfermant
ES455691A1 (es) Procedimiento para la produccion de derivados de piperacina.
DE3683822D1 (de) Chartreusinderivate und salze, diese enthaltende antitumorzusammensetzungen und verfahren zu ihrer herstellung.
SE7411243L (de)
ES8308833A1 (es) "un metodo para la preparacion de 3-fenil-1-indanaminas".
DE3362260D1 (en) (-)-15-deoxyspergualin, a process for the preparation of the same, and a pharmaceutical composition containing the same
JPS5545681A (en) 88chloroo66hydroxyy55methylbenzoic acid derivative
DE69400352D1 (de) 3- oder 4-Glykosyloxybenzopyranderivat und dieses enthaltende antiallergisches Mittel
ATE24834T1 (de) Verwendung von beta-(1-adamantyl)-alpha, alphadimethylethylamin zur herstellung eines arzneimittels zur behandlung von otitis externa bei hunden.
NO164474C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive heksahydropyrrolo(2,1-a)isokinolin-derivater.
ES8303299A1 (es) Procedimiento de preparacion de un nuevo derivado de acido benzamido-alquil-hidroxamico.
ES8300747A1 (es) Procedimiento para la preparacion de derivados de acido in- dolacetico
ES8105725A1 (es) Procedimiento para la preparacion de nuevas ureas sustitui- das con radicales basicos
DE3884878T2 (de) Uricosuretische Zusammensetzung.
ES467100A1 (es) Un procedimiento para la obtencion de (+,-)-cis-alfa-(3- (2,6-dimetil-1-piperidinil) propil)alfa-fenil-2-piridin-me- tanol.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee